These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7963752)

  • 21. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis of 18F-FDG with FDG MicroLab system: basic studies for clinical application].
    Kuge Y; Tsukamoto E; Katoh C; Seki K; Ohkura K; Ohmiya Y; Nishijima K; Tanaka A; Sasaki M; Tamaki N
    Kaku Igaku; 1999 Oct; 36(8):873-8. PubMed ID: 10586548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
    Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
    Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
    Brock CS; Meikle SR; Price P
    Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
    Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18F]-labeled 3-deoxy-3-fluoro-D-glucose: synthesis and preliminary biodistribution data.
    Tewson TJ; Welch MJ; Raichle ME
    J Nucl Med; 1978 Dec; 19(12):1339-45. PubMed ID: 104019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
    Scheidhauer K; Scharl A; Pietrzyk U; Wagner R; Göhring UJ; Schomäcker K; Schicha H
    Eur J Nucl Med; 1996 Jun; 23(6):618-23. PubMed ID: 8662094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers.
    Bruce DM; Evans NT; Heys SD; Needham G; BenYounes H; Mikecz P; Smith FW; Sharp F; Eremin O
    Eur J Surg Oncol; 1995 Jun; 21(3):280-3. PubMed ID: 7781797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
    Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
    J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)].
    Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J
    Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450
    [No Abstract]   [Full Text] [Related]  

  • 33. Routine 18F-2-deoxy-2-fluoro-D-glucose (18F-FDG) myocardial tomography using a normal large field of view gamma-camera.
    Höflin F; Ledermann H; Noelpp U; Weinreich R; Rösler H
    Angiology; 1989 Dec; 40(12):1058-64. PubMed ID: 2596740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of the PET bone agent (18)F-fluoride ion, simultaneously with (18)F-FDG by a single run of the medical cyclotron with minimal radiation exposure- a novel technique.
    Kumar R; Sonkawade RG; Tripathi M; Sharma P; Gupta P; Kumar P; Pandey AK; Bal C; Damle NA; Bandopadhayaya G
    Hell J Nucl Med; 2014; 17(2):106-10. PubMed ID: 25097896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
    Drane WE; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1995 Nov; 197(2):341-2; discussion 343. PubMed ID: 7480674
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
    Miyauchi T; Wahl RL
    Eur J Nucl Med; 1996 May; 23(5):517-23. PubMed ID: 8698055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
    Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
    Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.